Rosen Comments on Implications of Delay on Passing FDARA

25 July 2017 Pink Sheet News

Partner David Rosen told Pink Sheet in an article, “FDA Gives Congress Reprieve on Deadline for Passing User Fee Bill,” that most Senators are still pushing to get the FDA Reauthorization Act done prior to October 1, 2017.

FDA Commissioner Gottlieb recently sent a memo to all FDA employees that it does not plan to send reduction in force notices on August 1, 2017 to employees that could lose their jobs if FDARA is not enacted by October 1, 2017. “Gottlieb would not be telling employees about his plans unless the agency was "comfortable that they have assurances that the bill is going to pass,” Rosen said.

(Subscription required to read)

Related Services

Insights

Text Messages, EDiscovery, and the New Threat to Privacy
21 November 2019
CMS Proposes Enhanced Scrutiny over Medicaid Supplemental Payments
20 November 2019
Health Care Law Today
The Purpose of a Corporation
November 2019
Legal News: Business Law
Should This Be a "Mobility" Industry Blog?
19 November 2019
Dashboard Insights
PATH Summit 2019
18-20 December 2019
Arlington, VA
Madison CLE Days
18-19 December 2019
Madison, WI
MedTech Impact Expo & Conference
13-15 December 2019
Las Vegas, NV
HFMA MA-RI Annual Compliance Update
12 December 2019
Boston, MA